Theravance Biopharma (TBPH) Reports Q4 Loss Per Share of $1.23

Theravance Biopharma (NASDAQ: TBPH) reported Q4 EPS of ($1.23), versus ($2.02) reported last year. Revenue for the quarter came in at $3.9 million, versus $1.4 million reported last year.

For earnings history and earnings-related data on Theravance Biopharma (TBPH) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2
• Corpay agrees to $100M FTC settlement over marketing practices